Prof. Dr. Aytaç Atamer

Prof. Dr. Aytaç Atamer

Online Dəstək!

+994 10 311 50 55

Prof. Dr. Aytaç Atamer

Gastroenteroloq - Hepatoloq
Eğitim:
  • İstanbul Üniversitesi İstanbul Tıp Fakültesi / 1987 Dicle Üniversitesi / İç Hastalıkları / 1992 (Uzmanlık Eğitimi) Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / Gastroenteroloji / 2011 (Yan Dal) Haydarpaşa Numune Eğitim ve Araştırma Hastanesi / 2011 (İç Hastalıkları Doçenti) Yalova Üniversitesi / Gastroenteroloji / 2016 (İç Hastalıkları Profesör)
Makaleleri
  • Seçilmiş Yayınlar: A. Uluslararası hakemli dergilerde yayımlanan makaleler A1. Bayhan, G., Atamer, Y., Atamer, A., Koçyiğit, Y., “Evaluation of the placental lipid peroxides, glutathione peroxides activities and their relationship with serum lipoproteins in preeclamptic pregnancies”, Nagoya Med.J, 43: 53-64, (1999). A2. Bayhan, G., Atamer, Y., Atamer, A., Yokus, B., Koçyiğit, Y., “Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia”, Clin.Exp.Obst & Gyn, XXVII.n.2, 142-146, (2000). A3. Kocyigit, Y., Atamer, Y., Atamer, A., Tuzcu, A., Akkus, Z., “ Changes in serum levels of leptin, cytokines and lipoprotein in the preeclamptic and normotensive pregnant women”, Gynecological Endocrinology, 19(5): 267-73, (2004). A4. Kocyigit, Y., Bayhan,G., Atamer, A., Atamer,Y., “Serum Levels of Leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance”, Gynecological Endocrinology, 18: 341-348, (2004). A5. Atamer, Y., Erden, A.C., Demir, B., Kocyigit, Y., Atamer, A., “The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women”, Acta. Obstet.Gynecol.Scand, 83(4): 425-430, (2004). A6. Atamer, Y., Koçyigit, Y.,Yokus, B., Atamer, A., Erden, A.C., “Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia,” Eur.J.Obstet.Gynecol, 119(1): 60-66, (2005). A7. Bayhan, G., Koçyigit, Y., Atamer, A., Atamer,Y., Akkus, Z., “Potential atherogenic roles of lipids, lipoprotein(a), and lipid peroxidation in preeclampsia,” Gynecological Endocrinology, 21(1):1-6, (2005). A8. Atamer, A., Ilhan, N., Kocyigit, Y., Toprak, G., Ozbay, M., Celik, Y., ‘’ The Role of Asymmetric Dimethylarginine (ADMA) and Leptin in Hypertensive Patients ‘’ , J Int Med Res, 36:54-62, (2008). A9. Atamer, A., Demir, B., Bayhan, G., Atamer, Y., Ilhan, N. and Akkus, Z., ‘’ Serum levels of Leptin and Homocysteine in women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters’’, J Int Med Res, 36:96-105, (2008). A10. Atamer, A., Kocyigit, Y., Ecder, S.A., Selek, S., Ilhan, N., Ecder, T., Atamer, Y., ‘’Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease’’, Journal of Nephrology, 21(6):924-930, (2008). A11. Atamer, A., Ecder, S.A., Akkus, Z., Kocyigit, Y., Atamer, Y., Ilhan, N., Ecder, T., ‘’Relationship between Leptin, Insulin Resistance, Insulin-like Growth Factor-1(IGF-1) and Insulin-like Growth Factor Binding Protein-3(IGFBP-3) in Patients with Chronic Kidney Disease’’, J Int Med Res, 36:522-528, (2008). A12. Atamer, A., Bilici, A., Selek, S., Ilhan, N., Atamer, Y.,’’Importance of Paraoxonase (PON1) Activity, Nitric Oxide and Lipid Peroxidation in Hepatosteatosis’’, J Int Med Res, 36:771-776, (2008). A13. Demir, B., Guven, S., Atamer, Y., Kocyigit, Y., Hekimoglu, A., Toprak, G., Atamer, A., “Plasma Levels Of Lipids, Lipoproteins And Paraoxonase Actıvity In Preeclampsia. ” J Int Med Res, 39:4, (2011). A14. Demir, B., Demir, S., Atamer, Y., Guven, S., Atamer, A., Kocyigit, Y.,’’The Role Of Homocysteine, Asymmetric Dimethylarginine And Nitric Oxide In Preeclampsia’’. J Int Med Res, 39:5, (2011). A15. Atamer, Y., Atamer, A., Can, AS., Hekimoğlu, A., Ilhan, N., Yenice, N., Kocyigit, Y., ‘’Effects of Rosiglitazone on the serum Paraoxonase Activity and Metabolic Parameters in Patients with Type 2 Diabetes Mellitus’’, Braz J Med Biol Res, 46: 528-532, (2013). A16. Atamer, A., Kurdas Ovunc, AO., Yeşil, A., Atamer, Y., ’’Evaluation of Leptin and Insulin Resistance in patients with cholelithiasis’’, Indian J Biochem & Biophysics, 50: 266-272, (2013). A17. Atamer, A., Kurdaş Ovunç, AO., Yeşil, A., Atamer, A.,’’Evaluation of paraoxonase, malondialdehyde and lipoprotein levels in patients with asymptomatic cholelithiasis’’, Saudi J Gastroenterology, 19(5): 239-245, (2013). B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler: B1. Atamer, A., Selek, S., Kocyigit, Y., Ilhan, N., Sen, T. and Atamer, Y., ‘’Effects of Rosiglitazone on the serum Paraoxonase Activity and Metabolic Parameters in Patients with Type 2 Diabetes Mellitus’’, European Atherosclerosis Society, 76th Congress, Helsinki, Finland, June 10-13, (2007). B2. Atamer, A., İlhan, N., Koçyiğit, Y., Toprak, G., Özbay, M., Çelik, Y., “The Role of Asymmetric Dimethylarginine(ADMA) and Leptin in Hypertensive Patients”, European Atherosclerosis Society, 76th Congress, Helsinki, Finland, June 10-13, (2007). B3. Atamer, A., Demir, B., Bayhan, G., Atamer, Y., Akkuş, Z., ‘’Serum Levels of Leptin and Homocystein in women with PCOS and its Relation to Endocrine, Clinical and Metabolic Parameters’’, 7th International Congress on CORONARY ARTERY DISEASE from Prevention to Intervention, Venice, Italy, October 7-10, (2007). B4. Sarac, S., Atamer, Y., Bozkurt Yigit N., Kocyigit Y., Uslu, T., Atamer, A., ‘’Serum Para oxonase (PON-1) Activities, Nitric Oxide (NO) and Malondialdehyde (MDA) Levels are Al-tered in Patients with Primer Fibromyalgia Syndrome (PFS)’’, 6 th World Congress of Inter- national Society of Physical and Rehabilitation Medicine, Peurto Rico, (2011). B5. Sarac, S., Atamer, Y., Cevik, R., Nas, K., Kocyiğit, Y., Atamer, A., ‘’ Serum Leptin, IGF-1, IGF-2, IGFBP-3 Levels and Relation between Clinical Parameters in Patients with Primer Fibromyal-gia Sendrom (FMS) ‘’, 6 th World Congress of International Society of Physical and Rehabilitation Medicine, Peurto Rico, (2011). B6. Demir B, Guven S, Atamer Y, Kocyigit Y, Hekimoglu A, Toprak G, Atamer A. Plasma Levels Of Lipids, Lipoproteins And Paraoxonase Actıvity In Preeclampsia. IX th International Congress of the Turkish-German Gynecological Association, 4-8 may. Su sesi resort hotel Belek- Antalya, Turkey, 2011. B7. Demir B, Atamer Y, Guven S, Kocyigit Y, Hekimoglu A, Toprak G, Atamer A. The Role Of Homocysteıne, Asymmetrıc Dımethylargınıne And Nıtrıc Oxıde In Preeclampsıa. IX th International Congress of the Turkish-German Gynecological Association, 4-8 may. Su sesi resort hotel Belek- Antalya, Turkey, 2011. B8. Atamer, Y., Yenice, N., , Atamer, A., Selek, S., Tacyıldız, I., Koçyigit, Y., Bilici, A., ‘’Serum Prolidase, Superoxide Dismutase (SOD), Catalase (CAT) Activities And Oxidative Stress In Cholelitiasis’’, The 4th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus, Paris, France, December 1-4, (2011). B9. Atamer, A., Bilici, A., Atamer, Y., Taçyıldız, I., Koçyiğit, Y., Yenice, N., ’’Is Leptin and Insulin Resistance is Associated with Lipoproteins in Patients with Cholelitiasis’’, The 4th In- ternational Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemi- a and Diabetes Mellitus, Paris, France, December 1-4, (2011). B10. Atamer, A., Kurdas Ogun, A.O., Can, A.S., Yeşil, A., Atamer, Y., "Assessment of cardiometabolic risk factors in asymptomatic cholelithiasis" , The 2nd Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Rio de Janeiro, Brazil, March 22-25, (2012). B11. Atamer, A., Kurdas Ogun, A.O., Yeşil, A., Atamer, Y., "Clinical and Metabolic Risk Evaluation of Leptin and Insulin Resistance Changes In Patients With Cholelithiasis", The 2nd Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Rio de Janeiro, Brazil, March 22-25, (2012). B12. Atamer, A., Can, AS., Kurdas Ogun, A.O., Yeşil, A., Atamer, Y., ‘’Paraoxonase, malondialdehyde, and lipids in subjects with asymptomatic gallstones’’, 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE-ECE 2012), Floransa, Italy, March 5-9, (2012). B13. Atamer, Y., Atamer, A., Can, A.S., Yenice, N., Başak, M ., Saraç, S., Koçyiğit, Y., "Alterations of Paraoxonase, Superoxide Dismutase and Catalase Activities, Asymmetric Dimethylarginine, Nitric Oxide and Homocysteine Levels in Patients with Type 2 Diabetes Mellitus’’, The 1nd China Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Shanghaı, China, September 13-15, (2012). B14. Atamer, Y., Atamer, A., Yenice, N., Can, A.S., Koçyiğit, Y., " Cytokines, Adipocytokines and Insulin Resistance in NAFLD Patients with and without Type 2 Diabetes Mellitus : Association with Metabolic, Biochemical and Clinical Features’’, The 1nd China Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Shanghaı, China, September 13-15, (2012). B15. Ayeser, T., Başak, M., Pakır, E., Can, A.S., Saraç, S., Atamer, Y., ‘’The relationship between the number of metabolic syndrome components and adipocytokines, leptin and abdominal adipose tissue’’, The 4nd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Barcelona, Spain, November 8-11, (2012). B16. Turan, G., Basak, M., Saler, T., Sarac, S., Atamer, Y., ‘’ Effectiveness of Intramuscular Stimulation Treatment in Patients with Chronic Myofascial Pain’’, The 4nd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) , Barcelona, Spain, November 8-11, (2012) C. Ulusal hakemli dergilerde yayımlanan makaleler C1. Atamer, A., Koçyiğit, Y., Aydınol, B., ‘’ KBY’de Tiroid Hormonları ve Protein Fraksiyonlarının İncelenmesi’’, Dicle Tıp Dergisi, 20(1): 75-82, (1993). C2. Atamer, A., Koçyiğit, Y., Aydınol, B., “ Tip II Diabetes Mellitus’lularda Tiroid Hormonları ve Protein Fraksiyonlarının İncelenmesi’’, Dicle Tıp Dergisi, 20(2): 87-94,(1993). C3. Koçyiğit, Y., Aydınol, B., Çolpan, L., Atamer, A., ‘’ Kronik Renal Yetmezlikte Eritrosit Glukoz -6- Fosfat Dehidrogenaz Aktivitesi ‘’, Biyokimya Dergisi, XVIII (2): 35-42, (1993). C4. Mete, N., Atamer, Y., Atamer, A., Taşkapan, Ç., “Esansiyel Hipertansiyonlu Olgularda Serum Lipid Peroksidasyonu ve Kalsiyum Kanal Blokerlerinin Etkisi’’, Dicle Tıp Dergisi, 22(2/B): 77-82, (1995). C5. Batun., S., Atamer, Y., Koçyiğit, Y., Atamer, A., Canoruç, N., “Akut Myokard İnfarktüsü’nde Serum ve Eritrosit Lipid Peroksitlerindeki Değişikliklerin İncelenmesi”, Dicle Tıp Dergisi, 23(1):69-76, (1996). C6. Atamer, Y., Koçyiğit, Y., Batun, S., Canoruç, N., Atamer A., Erdem, İ., Deniz M., “Renal İskemi- Reperfüzyon Hasarında Verapamil ve Allopurinol’ün Etkileri”, Dicle Tıp Dergisi, 23 (1):49-57, (1996). C7. Atamer, Y., Atamer, A., Canoruç, N., Koçyiğit, Y., Turgut, C., “Aterosklerotik Kalp Hastalıklarında Serum Lipid Peroksidi ile Lipoprotein Düzeyleri Arasındaki İlişki”, Dicle Tıp Dergisi, 23(2): 9-16 , (1996). C8. Atamer, Y., Hoşoğlu, S., Mete, M., Ceviz, A., Koçyiğit, Y., Atamer, A., ‘’Deneysel Menenjitte Lipid Peroksitleriyle Antioksidanların Rolü ve Seftriakson-Diklofenak Sodyum ile Etkileşimi’’, İnfeksiyon Dergisi, 11(1):43-47, (1997). C9. Atamer, Y., Koçyiğit, Y., Atamer, A., Canoruç, N., Toprak, G., “Investigation of the effect of vitamin E against carbon tetraclorur hepatotoxicity and alterations of glutathione, glutathione peroxidase”, Turk J Gastroenterol, 8:375-380, (1997). C10. Atamer, Y., Mete, N., Koçyiğit, Y., Atamer, A., Canoruç, N., Çelik, S., “Lipid Peroxidation, Lipoprotein and Trace Element Alterations in Type II Diabetics”, Türkiye Tıp Dergisi, 4(2): 77-81, (1997). C11. Atamer, Y., Koçyiğit, Y., Atamer, A., Mete, N., Canoruç, N., Ketani, A., “Role of oxidants-antioxidants and radical scavengers in alcohol-induced liver injury in rats”, Turk J Endocrinol, 8:137-143, (1997). C12. Atamer, Y., Koçyiğit, Y., Atamer, A., Mete, N., Canoruç, N., Toprak, G., “Alterations of Erythrocyte and Plasma Lipid Peroxides as well as Antioxidant Mechanism in Patients with Type II Diabetes Mellitus (NIDDM)”, Tr J of Medical Sciences, 28:143-148, (1998). C13. Atamer, Y., Koçyiğit, Y., Atamer, A., Mete, N., Canoruç, N., “Significance of lipid peroxides, glutathione and antiperoxidative enzymes in ethanol and acetaminophen toxicity in rat”, Turk J Gastroenterol, 11(1):54-60, (2000). C14. Canoruç, N., Çiçek, R., Atamer, A., Dursun, M., Turgut, C., Güneli, E., Canoruç, F., ‘’Protective Effect of Vitamin E, Selenium and Allopurinol Against Stress-Induced Ulcer Formation in Rats’’, Tr J of Medical Sciences, 31:199-203, (2001). C15. Atamer, Y., Atamer, A., “ Lipoprotein(a)(Lp(a), Apolipoproteinler, ve Tip II Diabetes Mellitus”, Dicle Tıp Dergisi, 29(3): 13-19, (2002). C16. Atamer, Y., Atamer, A., “ Lipoprotein(a)(Lp(a) ve Serum Lipidlerinin Aterosklerotik Olgulardaki Değişikliklerinin İncelenmesi’’, Dicle Tıp Dergisi, 29(4): 31-36, (2002) E. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler: E1. Bayhan, G., Atamer Y., Atamer A., Koçyiğit Y., “Evaluation of the placental lipid peroxides, glutathion peroxides activities and their relationship with serum lipoproteins in preeclamptic and eclamptic pregnancies,” II. Ulusal Jinekoloji ve Obstetrik Kongresi, 3-7 Ekim, Sirene City, Antalya, p85, (1999). E2. Bayhan, G., Atamer, Y., Atamer, A., Yokuş, B., Baylan Koçyiğit, Y., Erden, A.C., “Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia,” Maternal Fetal Tıp ve Perinatoloji Kongresi, 6-8 Nisan, İstanbul, (2000). E3. Atamer, Y., Atamer, A., ‘’Lipoprotein(a)(Lp(a) ve Serum Lipidlerinin Aterosklerotik Olgulardaki Değişikliklerinin İncelenmesi”, Tanıda Moleküler Tıp Sempozyumu, 5-8 Haziran, Diyarbakır,(2003). E4. Atamer, Y., Atamer, A., “Lipoprotein(a)(Lp(a), Apolipoproteinler, ve Tip II Diabetes Mellitus”, Tanıda Moleküler Tıp Sempozyumu, 5-8 Haziran, Diyarbakır, (2003). E5. Ünal, H., Atamer, Y., Canoruç, N., Atamer, A., Koçyiğit, Y.,“Tip 2 Diabetes Mellituslu Hastalarda İnsülin Rezistansı ve IGF-1, IGFBP-3 Düzeyleri arasındaki İlişkilerin İncelenmesi,” 6. Ulusal İç Hastalıkları Kongresi, 14-19 Eylül, Kemer, Antalya, P006, (2004). E6. Atamer, Y, Koçyiğit, Y., Yokuş, B., Atamer, A., Erden, A.C.,“Preeklampside lipid peroksidasyonu, antioksidan savunma, leptin düzeyleri ve iz elementlerin durumu“, II.Leptin Kongresi, 8-10 Ekim, Ankara, PS12, (2004). E7. Koçyiğit,Y., Bayhan, G., Atamer, Y., Atamer, A., “Preeklampsili Hamile Kadınlarda Serum Leptin, IGF-I, IGFBP-3 ve İnsülin Rezistansı ile Aralarındaki İlişkiler“, II.Leptin Kongresi, 8-10 Ekim, Ankara, PS15, (2004). E8. Koçyiğit, Y., Atamer, Y., Atamer, A., Tuzcu, A., Akkuş, Z., “Preeklamptik ve Sağlıklı Hamile Kadınlarda Leptin,Sitokin ve Lipoprotein Düzeylerindeki Değişiklikler’’, II.Leptin Kongresi, 8-10 Ekim, Ankara, PS5, (2004). E9. Bayhan, G., Koçyiğit, Y., Atamer, A., Atamer, Y., Akkuş, Z., “ Potential Atherogenic Roles of Lipids, Lipoprotein(a) and Lipid Peroxidation in Preeclampsia”, P004, I. Ulusal Moleküler Tıp Kongresi, 16-19 Nisan, İstanbul, (2005). E10. Atamer, Y., Erden, A.C., Demir, B., Koçyiğit, Y., Atamer, A., “ The Relationship Between Plasma Levels of Leptin and Androgen in Healthy and Preeclamptic Pregnant Women”, P005, I. Ulusal Moleküler Tıp Kongresi, 16-19 Nisan, İstanbul, (2005). E11. Atamer, A., Bahçeci, M., Tuzcu, A., Şen, T., Erel, Ö., “ Komplikasyonlu ve Komplikasyonsuz Tip 2 Diabetes Mellitus’lu Hastalarda Serum Paraoksonaz aktivitesi, Lipid Peroksidasyonu ve Lipoproteinlerle İlişkileri”, P04, 41. Ulusal Diabet Kongresi, 11-15 Mayıs, Antalya, (2005). E12. Atamer, A., Koçyiğit, Y., Şen, T., ‘’ Kronik Böbrek Yetmezliği Olgularında Oksidatif Stresin Serum Paraoksonaz, Eritrosit SOD ve Katalaz Enzim Aktivitelerine Etkileri’’, P39, VII. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 25-29 Mayıs, Antalya, (2005). E13. Atamer, A., Şen, T., Taçyıldız, İ., Koçyiğit, Y., “ Sıçanlarda Parasetamol ve Etanol Toksisitesinde Azalmış Serum Paraoksonaz Aktivitesi ve Lipid Peroksidasyonu ile İlişkisi”, P111, V. Ulusal Hepatoloji Kongresi, 5-7 Haziran, İstanbul, (2005). E14. Atamer, Y., Atamer, A., Şen, T., Taçyıldız, İ., Koçyiğit, Y., “ Kolelitiyazisli olgularda Paraoksonaz ve Antioksidan Enzim Aktivitelerinin Preoperatif ve Postoperatif Dönemde İncelenmesi”, P007, V. Ulusal Hepatoloji Kongresi, 5-7 Haziran,İstanbul, (2005). E15. Atamer, A., Bilici, A., Koçyiğit, Y., Meriç, K., Tümer, C., “ Non-Alkolik Yağlı Karaciğer Hastalığında Homosistein, Lipoprotein(a) Değişiklikleri ve Kardiyovasküler Risk Faktörleri”, P198, 7. Ulusal İç Hastalıkları Kongresi, 16-20 Eylül, Antalya, (2005). E16. Atamer, A., Ecder, S., Akkuş, Z., Koçyiğit, Y., Atamer, Y., Ecder, T., “Relationship between leptin, insulin resistance IGF-1 and IGFBP-3 in patients with mild chronic renal failure’’, 2nd Congress of Molecular Medicine, 24-26 March, İstanbul, (2007) F. Yazılan uluslararası kitaplar veya kitaplarda bölümler Atamer A, Alisir Ecder S, Atamer Y, Kocyigit Y, Bozkurt Yigit N and Ecder T. ‘’The Effects of Asymmetric Dimet- hylarginine(ADMA), Nitric Oxide(NO) and Homocysteine(Hcy) on Progression of Mild Chronic Kidney Disease(CKD): Relationship Between Clinical and Biochemical Parameters’’. (ISBN 978-953-51-0171-0), Chronic Kidney Disease, Section 12, Page 197-208, (2012) G. Diğer yayınlar G1. Atamer, A., Atamer, Y., Can, AS., Bilici, A., Taçyıldız, I., Koçyiğit, Y.,’’Leptin is associated with lipoproteins in patients with cholelithiasis’’ J Int Med Res, İncelemede. G2. Atamer, Y., Atamer, A., Can, AS., Yenice, N., Tacyildiz, I., Kocyigit, Y., Bilici, A., ‘’Serum Prolidase, Superoxide Dismutase, Catalase Activities and Oxidatif Stress in Cholelitiasis’’, Indian J Biochem & Biophysics, İncelemede. G3. Atamer, Y., Demir, B., Atay, AE., Demir, S., Atamer, A., Kocyigit, Y., Gül, T., ‘’Rela- tion of Serum Paraoxonase Activity and Oxidative Stress in Patients with Polycystic Ovary Syndrome’’, Gynecol Endocrinology, İncelemede. G4. Saraç, S., Atamer, Y., Gür, R., Koçyiğit, Y., Nas, K., Atamer, A.,‘’ Serum Leptin,IGF-1, IGF-2, IGFBP-3 Levels and Relation between Clinical Parameters in Patients with Primer Fibromyalgia Sendrom (FMS) ‘’, Disability and Rehabilitation, İncelemede. G5. Saraç, S., Atamer, Y., Bozkurt Yiğit, N., Koçyiğit, Y., Uslu, T., Atamer, A., ‘’Serum Paraoxonase(PON-1) Levels but not Nitric Oxide(NO) and Malondialdehyde(MDA) Levels are Altered in Patients with Primer Fibromyalgia Syndrome(PFS) ‘’, Disability and Rehabilitation,İncelemede. G6. Atamer, Y., Can, AS., Atamer, A., Yenice, N., Başak, M., Sarac, S., Koçyiğit, Y., ‘’ Alterations of Paraoxonase, Superoxide Dismutase and Catalase Activities, Asymmetric Dimethylarginine, Nitric Oxide and Homocysteine Levels in Patients with Type 2 Diabetes Mellitus’’, Int J of Endocrinology, İncelemede. H. Hakemlik SCI ve SCI Expanded kapsamındaki dergilerde hakemlik 1. Re: European Journal of Gastroenterology & Hepatology (EJGH5717), Title: Oral intake throughout the patients’ lives after palliative metalic stent placement for ma- lignant gastroduodenal obstruction: A retrospective multicentre study. Corresponding author: Dr.Jorge Canena, Accept for publication 2. ARCH-12-4828, Title: Medical Ozone Therapy Decreases Postoperativ Adhesion Formation in Rats. Accept for publication